Regulations/EU AI Act/Source Library
Source Library · EU AI Act

Source Library for EU AI Act.

This source library keeps official references, implementation status, and public-use boundaries visible for the workspace. It supports evidence-readiness without turning protected standards, guidance, or legal material into loose checklist language.

Source basis: Regulation (EU) 2024/1689Use: evidence-readinessBoundary: not legal advice
EU AI Act TRACE ARTICLE 3 DEFINITIARTICLE 4 AI LITARTICLE 5 PROHIBARTICLE 6 AND AN
/ Source discipline

What can be used publicly and what must stay bounded.

public-safe
Rule 01

Official source first

Use regulator, source-owner, EUR-Lex, FDA, EMA, ICH, ISO/IEC, ISPE, IMDRF, Health Canada, MHRA or similar authority/source-owner pages before commentary.

Rule 02

Paid-source boundary

Where a standard or guide is protected, the page names the source and describes public-safe implications without reproducing protected clause text.

Rule 03

Status visible

Every source needs date/status language so draft, final, watch item, and effective/applicable dates are not mixed.

Rule 04

Interpretation separated

Source fact and iFeed interpretation must remain visibly separated before any checklist is published.

/ Source objects

Objects that deserve stable child pages.

future expansion
Object 01

Article 3 definitions

Use for terms such as AI system, provider, deployer, importer, distributor, authorised representative, GPAI model, and serious incident.

Object 02

Article 4 AI literacy

Creates a practical training and competence evidence layer for providers and deployers from 2025-02-02.

Object 03

Article 5 prohibited practices

Early applicability gate; relevant before deeper classification work because some uses are not allowed.

Object 04

Article 6 and Annex III high-risk classification

Classification depends on intended purpose, role, EU nexus, and listed high-risk areas.

Object 05

Articles 8-15 high-risk system controls

Risk management, data governance, technical documentation, record keeping, transparency, human oversight, accuracy, robustness, and cybersecurity.

Object 06

Article 26 deployer obligations

Important for life-sciences and healthcare organisations using third-party systems.

Object 07

Article 50 transparency duties

Separate from high-risk status; user-facing disclosure may still apply.

Object 08

Articles 61-72 post-market and incident chain

Turns deployment into an ongoing evidence and reporting workflow.